Cleared Traditional

K103693 - VANTAGE ABI

K103693 is an FDA 510(k) clearance for VANTAGE ABI, manufactured by Summit Doppler Systems, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K103693 · Summit Doppler Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2011
Decision
60d
Days
Class 2
Risk

K103693 is an FDA 510(k) clearance for the VANTAGE ABI. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Summit Doppler Systems, Inc. (Golden, US). The FDA issued a Cleared decision on February 15, 2011 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Summit Doppler Systems, Inc. devices

FDA 510(k) Submission Details - K103693

510(k) Number K103693 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 17, 2010
Decision Date February 15, 2011
Days to Decision 60 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 125d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 661
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K103693.
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR MODEL KD-931
K102939 · Andon Health Co, Ltd. · Feb 2011
INFINITY CNAP SMARTPOD
K102968 · Draeger Medical Systems, Inc. · Feb 2011
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K110330 · Andon Health Co, Ltd. · Feb 2011
AVITA WRIST TYPE BLOOD PRESSURE MONITOR
K102624 · Avita Corporation · Dec 2010
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K102690 · Andon Health Co, Ltd. · Nov 2010
KD-931D FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K102631 · Andon Health Co, Ltd. · Nov 2010